Astellas Institute for Regenerative Medicine
Clinical trials sponsored by Astellas Institute for Regenerative Medicine, explained in plain language.
Now part of
Astellas Pharma Inc.
4503
TOKYO
Research arm of Astellas Pharma focused on regenerative medicine.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.